These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18032598)

  • 21. The effects of Japanese encephalitis virus antibodies on Zika virus infection.
    He X; Lang X; Yu J; Zhu L; Qin Z; Liu X; Chen P; Dai C; Chen T; Li X; Chen Y; Zhou D; Fang W; Xiao W; Zhang B; Xie Q; Wu Q; Zhao W
    Med Microbiol Immunol; 2020 Apr; 209(2):177-188. PubMed ID: 32078028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of yearly changes in levels of antibodies to Japanese encephalitis virus nonstructural 1 protein in racehorses in central Japan shows high levels of natural virus activity still exist.
    Konishi E; Shoda M; Kondo T
    Vaccine; 2006 Jan; 24(4):516-24. PubMed ID: 16129523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and application of a monoclonal-antibody-based blocking ELISA for detection of Japanese encephalitis virus NS1 antibodies in swine.
    Zhou D; Pei C; Yang K; Ye J; Wan S; Li Q; Zhang L; Chen H; Cao S; Song Y
    Arch Virol; 2019 Jun; 164(6):1535-1542. PubMed ID: 30900070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonstructural protein 1-specific immunoglobulin M and G antibody capture enzyme-linked immunosorbent assays in diagnosis of flaviviral infections in humans.
    Chao DY; Galula JU; Shen WF; Davis BS; Chang GJ
    J Clin Microbiol; 2015 Feb; 53(2):557-66. PubMed ID: 25502522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of antibody to Japanese encephalitis virus nonstructural 1 protein among racehorses in Japan: indication of natural infection and need for continuous vaccination.
    Konishi E; Shoda M; Kondo T
    Vaccine; 2004 Mar; 22(9-10):1097-103. PubMed ID: 15003636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Roles of N-glycosylation in immunity of prME and NS1 gene of JEV].
    Zhang ZZ; Wang X; Zai JJ; Sun LQ; Song YF; Chen HC
    Bing Du Xue Bao; 2012 May; 28(3):213-8. PubMed ID: 22764522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-expression of Japanese encephalitis virus prM-E-NS1 antigen with granulocyte-macrophage colony-stimulating factor enhances humoral and anti-virus immunity after DNA vaccination.
    Gao N; Chen W; Zheng Q; Fan DY; Zhang JL; Chen H; Gao GF; Zhou DS; An J
    Immunol Lett; 2010 Mar; 129(1):23-31. PubMed ID: 20064558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ratios of subclinical to clinical Japanese encephalitis (JE) virus infections in vaccinated populations: evaluation of an inactivated JE vaccine by comparing the ratios with those in unvaccinated populations.
    Konishi E; Suzuki T
    Vaccine; 2002 Nov; 21(1-2):98-107. PubMed ID: 12443667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The A66G back mutation in NS2A of JEV SA14-14-2 strain contributes to production of NS1' protein and the secreted NS1' can be used for diagnostic biomarker for virulent virus infection.
    Wang J; Li X; Gu J; Fan Y; Zhao P; Cao R; Chen P
    Infect Genet Evol; 2015 Dec; 36():116-125. PubMed ID: 26384477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of recombinant nonstructural 1 protein based indirect enzyme linked immunosorbent assay for sero-surveillance of Japanese encephalitis in swine.
    Dhanze H; Bhilegaonkar KN; Rawat S; Chethan Kumar HB; Kumar A; Gulati BR; Mishra BP; Singh RK
    J Virol Methods; 2019 Oct; 272():113705. PubMed ID: 31351167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Japanese Encephalitis Virus NS1' Protein Antagonizes Interferon Beta Production.
    Zhou D; Jia F; Li Q; Zhang L; Chen Z; Zhao Z; Cui M; Song Y; Chen H; Cao S; Ye J
    Virol Sin; 2018 Dec; 33(6):515-523. PubMed ID: 30542978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Japanese encephalitis virus structural and nonstructural proteins expressed in Escherichia coli induce protective immunity in mice.
    Tafuku S; Miyata T; Tadano M; Mitsumata R; Kawakami H; Harakuni T; Sewaki T; Arakawa T
    Microbes Infect; 2012 Feb; 14(2):169-76. PubMed ID: 22001496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive mapping of West Nile virus (WNV)- and Japanese encephalitis virus serocomplex-specific linear B-cell epitopes from WNV non-structural protein 1.
    Sun EC; Zhao J; Liu NH; Yang T; Ma JN; Geng HW; Wang LF; Qin YL; Bu ZG; Yang YH; Lunt RA; Wang LF; Wu DL
    J Gen Virol; 2012 Jan; 93(Pt 1):50-60. PubMed ID: 21940411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of an in vitro antigen-detection test as an alternative method to the in vivo plaque reduction neutralization test for the quality control of Japanese encephalitis virus vaccine.
    Kim DK; Kim HY; Kim JY; Ye MB; Park KB; Han E; Kim J; Ja Ban S; Hong SH; Park YK; Nam JH
    Microbiol Immunol; 2012 Jul; 56(7):463-71. PubMed ID: 22486472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [To evaluate the neutralizing abilities of anti-dengue virus antibodies with nonstructural protein 1 antigen capture enzyme-linked immunosorbent assay].
    Wen K; Ding YQ; Qiu LW; Pan YX; Cai JP; Yue CF; DI B; Che XY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Aug; 43(8):680-5. PubMed ID: 20021846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Japanese encephalitis virus immunoglobulin M antibodies in porcine sera.
    Burke DS; Tingpalapong M; Elwell MR; Paul PS; Van Deusen RA
    Am J Vet Res; 1985 Oct; 46(10):2054-7. PubMed ID: 2998237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific antibody responses to West Nile virus infections in horses preimmunized with inactivated Japanese encephalitis vaccine: evaluation of blocking enzyme-linked immunosorbent assay and complement-dependent cytotoxicity assay.
    Kitai Y; Shirafuji H; Kanehira K; Kamio T; Kondo T; Konishi E
    Vector Borne Zoonotic Dis; 2011 Aug; 11(8):1093-8. PubMed ID: 21254919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced immune responses against Japanese encephalitis virus using recombinant adenoviruses coexpressing Japanese encephalitis virus envelope and porcine interleukin-6 proteins in mice.
    Liu H; Wu R; Liu K; Yuan L; Huang X; Wen Y; Ma X; Yan Q; Zhao Q; Wen X; Cao S
    Virus Res; 2016 Aug; 222():34-40. PubMed ID: 27235810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The C Terminus of the Core β-Ladder Domain in Japanese Encephalitis Virus Nonstructural Protein 1 Is Flexible for Accommodation of Heterologous Epitope Fusion.
    Yen LC; Liao JT; Lee HJ; Chou WY; Chen CW; Lin YL; Liao CL
    J Virol; 2016 Feb; 90(3):1178-89. PubMed ID: 26559836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccines.
    Chen HW; Pan CH; Liau MY; Jou R; Tsai CJ; Wu HJ; Lin YL; Tao MH
    J Virol; 1999 Dec; 73(12):10137-45. PubMed ID: 10559329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.